FDA, SpringWorks

Judge orders CDC, FDA to restore websites taken down

FDA’s plan to propose ban on formaldehyde in hair-straightening products remains in limbo under Trump administration
A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-releasing chemicals ...
Botulism fears prompt FDA to recall some canned tuna sold at popular retailers
A pull-tab defect that might cause leakage and lead to botulism contamination is affecting some canned tuna products sold in ...
The American Journal of Managed Care35m
FDA Approves Mirdametinib for Neurofibromatosis Type 1 with Plexiform Neurofibromas
Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that are not amenable ...
FDA fast tracks NKGen's Alzheimer's therapy troculeucel
SANTA ANA, Calif. - NKGen Biotech, Inc. (NASDAQ: NKGN), a clinical-stage biotechnology company with a current market ...
FiercePharma4h
Amid takeover talk, SpringWorks scores FDA nod for rare genetic disease treatment Gomekli
Tuesday, the agency signed off on SpringWorks’ Gomekli (mirdametinib) as a treatment for the rare genetic disorder ...
Rolling Out1d
FDA recalls millions of Dunkin’ treats over safety alert
FDA announces recall affecting millions of Dunkin' baked goods including beloved Munchkins, donuts, and fritters - here's ...
Scotiabank raises Travere stock target to $32 on FDA update
Scotiabank (TSX:BNS) analyst Greg Harrison increased the price target on Travere Therapeutics (NASDAQ:TVTX) to $32.00, up from the previous $27.00, while retaining a Sector Outperform rating for the ...
FOX13 Memphis6h
Tennessee Secretary of State urges businesses to join fight against human trafficking
COMBATING HUMAN TRAFFICKING - Tennessee Secretary of State Tre Hargett said Tuesday that just a little over 250 businesses ...